Primer: HeMo Bioengineering (HMB HK) - Aug 2026
HeMo Bioengineering is a privately held medical device company specializing in innovative interventional solutions for neurovascular and...
89 Views
Concerns and Outlook on China Neuro-Interventional Industry
The insight analyzed ChinaĀ neuro-interventionalĀ industry including the reason of cool-down in primary market, theĀ product homogenization, fierce...
678 Views
Pre-IPO HeMo Bioengineering - Insights on Industry, Business and Concerns
We analyzed the industry characteristics, the business and competitive landscape of HeMo. The centralized procurement, commercialization...
461 Views
ECM Weekly (31st October 2021) - Patym, PolicyBazaar, Nykaa, HeMo, Clover Bio, UJU, Airdoc, Mitratel
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
394 Views
HeMo Bioengineering (ē¦¾ęØēē©å·„ēØ) Pre-IPO: Signs of Lacking Innovation
We look at HeMo Bioengineering's main products. We are not convinced that its aspiration catheter products are innovative and competitive.
731 Views
No more insights